ntially could be incurred from
breaches of contracts or loss of customer data; the inability to protect
intellectual property rights or the infringement upon other's intellectual
property rights; the Company's success in integrating its acquisition's
operations into its own operations and the costs associated with
maintaining and/or developing two product suites; the Company's ability to
raise capital and general economic conditions such as the rate of
employment, inflation, interest rates and the condition of capital markets.
This list of factors is not all inclusive. In addition, the Company's
success depends on the outcome of various strategic initiatives it has
undertaken, all of which are based on assumptions made by the Company
concerning trends in the clinical research market and the health care
industry. The Company undertakes no obligation to update publicly or revise
any forward-looking statement.
DATATRAK International, Inc. and Subsidiaries
Condensed Consolidated Balance Sheet Data
(Unaudited)
December 31, December 31,
2007 2006
Cash and investments $8,514,361 $5,022,847
Accounts receivable, net 1,070,688 2,226,317
Property & equipment, net 3,534,799 4,736,233
Deferred tax assets 1,399,000 1,858,800
Intangible assets, net 520,458 1,914,206
Goodwill 10,856,113 10,856,113
Other 577,792 605,666
Total assets $26,473,211 $27,220,182
Accounts payable and other current liabilities $5,651,883 $3,709,485
Long
'/>"/>
SOURCE DATATRAK International, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 Related medicine news :1.
DATATRAK International Management to Host Conference Call on February 26, 2008 to Discuss Fourth Quarter and Full Year Operating Results for 20072.
DATATRAK Closes Second Multi-Year Enterprise Agreement with European Clinical Trial Sponsor3.
DATATRAK to Present at the Roth Capital Partners 20th Annual Orange County Stock Conference4.
DATATRAK International Launches Innovative, Interactive Educational Webcast Series5.
DATATRAK International, Inc. Announces 2007 Third Quarter and Nine Month Operating Results6.
DATATRAK International Management To Host Conference Call on November 8, 2007 To Discuss Third Quarter and Nine Month Operating Results for 20077.
PRA International to Open Expanded Clinical Pharmacology Center8.
International Federation of Sports Medicine Selects Celadrin(R) Topical Cream as its First and Only Official Joint and Muscle Topical Cream9.
2008 International Stroke Conference Highlights Impact of Merci Retrieval System10.
Pezcoller Foundation-AACR International Award for Cancer Research recognizes Axel Ullrich11.
Logistical information for the 2008 International Stroke Conference